Enhancing mRNA therapy through iterative delivery
Science Advances · 2025
DOI: 10.1126/sciadv.adx0916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Joshua Seaberg und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA. Hauptthemen laut MEDLINE: RNA, Messenger, Metal Nanoparticles, Gene Transfer Techniques, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Clinical translation of therapeutic messenger RNA (mRNA) technologies, particularly in solid tumors, has been limited due to unavailability of effective delivery systems. Here, we describe an mRNA delivery system that overcomes current challenges by co-encapsulating gold nanoparticles (AuNPs) and mRNA within non-ionic surfactant vehicles (NSVs) to create “Aurniosoves” (AuNSVs). Through in vitro and in vivo studies, we demonstrate that AuNSVs improve vector accumulation and uptake within the tumor, resulting in enhanced protein expression and therapeutic efficacy. Mechanistically, these effects are the result of an iterative delivery process in which AuNSVs enter cells initially through clathrin-mediated endocytosis (CME) and release AuNPs into the cytoplasm. AuNPs subsequently adsorb and inactivate cellular trafficking regulators PP2A and Rab7, producing two effects: (i) rapid entry of additional AuNSVs through activation of caveolin-mediated endocytosis (CvME) and (ii) endosomal escape through inhibited endolysosomal fusion. We propose that AuNSVs be exploited as next-generation mRNA delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA.
- Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA.
- Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA.
- OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA.
- Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA.
- Department of Microbiology and Immunology, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA.
ORCID-Profile: Joshua Seaberg, Suresh Kumar Gulla, Jocelyn Labombarde, Shailendra Kumar Dhar Dwivedi, Chao Xu, Susan Kovats, Resham Bhattacharya, Priyabrata Mukherjee
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Seaberg, J., Gulla, S. K., Labombarde, J., Roy, R., Dwivedi, S. K. D., Xu, C., Kovats, S., Bhattacharya, R., & Mukherjee, P. (2025). Enhancing mRNA therapy through iterative delivery. Science Advances. https://doi.org/10.1126/sciadv.adx0916
Vancouver
Seaberg J, Gulla SK, Labombarde J, Roy R, Dwivedi SKD, Xu C, et al. Enhancing mRNA therapy through iterative delivery. Science Advances. 2025. doi:10.1126/sciadv.adx0916
BibTeX
@article{Seaberg2025,
author = {Seaberg, Joshua and Gulla, Suresh Kumar and Labombarde, Jocelyn and Roy, Ram and Dwivedi, Shailendra Kumar Dhar and Xu, Chao and Kovats, Susan and Bhattacharya, Resham and Mukherjee, Priyabrata},
title = {Enhancing mRNA therapy through iterative delivery},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adx0916}
}
EUVIMED